The New England Journal of Medicine (2000;343:1430-8) published a study examining the impact of relapses on the progression of irreversible disability in multiple sclerosis (MS). The study analyzed data from 1844 patients with MS, who had been followed for a mean of 11 years. The researchers found that patients with a relapsing-remitting (RR) course of MS had significantly longer times to reach disability scores of 4, 6, and 7 on the Kurtzke Disability Status Scale compared to those with a progressive (P) course. However, once irreversible disability was present, the progression of disability was similar between the two groups. Additionally, the time course of progressive, irreversible disability was not affected by the presence or absence of superimposed relapses in patients with primary progressive MS. The study concluded that relapses do not significantly influence the progression of irreversible disability in MS. The findings suggest that the progression of disability in MS is primarily determined by the initial disease course rather than the occurrence of relapses. The study highlights the importance of early diagnosis and treatment in managing MS. The data were collected from a large, well-established database of MS patients, ensuring a comprehensive and representative sample. The study's results are consistent with other large studies on the natural history of MS, reinforcing the understanding of the disease's progression and the role of relapses in its development. The study also emphasizes the need for further research into the long-term effects of treatments on MS progression.The New England Journal of Medicine (2000;343:1430-8) published a study examining the impact of relapses on the progression of irreversible disability in multiple sclerosis (MS). The study analyzed data from 1844 patients with MS, who had been followed for a mean of 11 years. The researchers found that patients with a relapsing-remitting (RR) course of MS had significantly longer times to reach disability scores of 4, 6, and 7 on the Kurtzke Disability Status Scale compared to those with a progressive (P) course. However, once irreversible disability was present, the progression of disability was similar between the two groups. Additionally, the time course of progressive, irreversible disability was not affected by the presence or absence of superimposed relapses in patients with primary progressive MS. The study concluded that relapses do not significantly influence the progression of irreversible disability in MS. The findings suggest that the progression of disability in MS is primarily determined by the initial disease course rather than the occurrence of relapses. The study highlights the importance of early diagnosis and treatment in managing MS. The data were collected from a large, well-established database of MS patients, ensuring a comprehensive and representative sample. The study's results are consistent with other large studies on the natural history of MS, reinforcing the understanding of the disease's progression and the role of relapses in its development. The study also emphasizes the need for further research into the long-term effects of treatments on MS progression.